enVVeno Medical Corp
NASDAQ:NVNO
Income Statement
Earnings Waterfall
enVVeno Medical Corp
Income Statement
enVVeno Medical Corp
| Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||
| Revenue |
1
N/A
|
1
+5%
|
1
-33%
|
0
-24%
|
0
-33%
|
0
+14%
|
0
+3%
|
0
-42%
|
0
-5%
|
0
-44%
|
0
-40%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
(0)
N/A
|
0
N/A
|
0
-50%
|
0
N/A
|
0
N/A
|
0
+100%
|
0
+188%
|
0
-17%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(3)
|
(5)
|
(5)
|
(6)
|
(6)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(17)
|
(19)
|
(24)
|
(27)
|
(25)
|
(26)
|
(26)
|
(25)
|
(25)
|
(24)
|
(23)
|
(23)
|
(24)
|
(23)
|
(25)
|
(24)
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(11)
|
(14)
|
(16)
|
(18)
|
(15)
|
(14)
|
(13)
|
(12)
|
(11)
|
(11)
|
(11)
|
(12)
|
(11)
|
(11)
|
(13)
|
(12)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(12)
|
(13)
|
(13)
|
(14)
|
(13)
|
(12)
|
(12)
|
0
|
(12)
|
(12)
|
(12)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(5)
-37%
|
(5)
-16%
|
(6)
-15%
|
(6)
-5%
|
(8)
-29%
|
(8)
+4%
|
(8)
+6%
|
(8)
-2%
|
(7)
+15%
|
(7)
-5%
|
(7)
-4%
|
(8)
-7%
|
(7)
+5%
|
(7)
-1%
|
(9)
-26%
|
(10)
-14%
|
(11)
-8%
|
(12)
-7%
|
(17)
-40%
|
(19)
-13%
|
(24)
-24%
|
(27)
-16%
|
(25)
+9%
|
(26)
-6%
|
(26)
+1%
|
(25)
+3%
|
(25)
+2%
|
(24)
+4%
|
(23)
+6%
|
(23)
-4%
|
(24)
-3%
|
(23)
+3%
|
(25)
-7%
|
(24)
+5%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(1)
|
(2)
|
(6)
|
(8)
|
(8)
|
(7)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(5)
-33%
|
(6)
-23%
|
(8)
-26%
|
(11)
-46%
|
(15)
-33%
|
(14)
+5%
|
(13)
+9%
|
(10)
+24%
|
(7)
+31%
|
(7)
-5%
|
(8)
-7%
|
(7)
+6%
|
(7)
+4%
|
(7)
-2%
|
(9)
-30%
|
(11)
-18%
|
(11)
-7%
|
(12)
-4%
|
(17)
-39%
|
(19)
-15%
|
(24)
-25%
|
(27)
-16%
|
(25)
+10%
|
(26)
-4%
|
(25)
+2%
|
(24)
+4%
|
(24)
+0%
|
(22)
+8%
|
(21)
+7%
|
(21)
-3%
|
(22)
-4%
|
(21)
+3%
|
(23)
-8%
|
(22)
+5%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(5)
|
(6)
|
(8)
|
(11)
|
(15)
|
(14)
|
(13)
|
(10)
|
(7)
|
(7)
|
(8)
|
(7)
|
(7)
|
(7)
|
(9)
|
(11)
|
(11)
|
(12)
|
(17)
|
(19)
|
(24)
|
(27)
|
(25)
|
(26)
|
(25)
|
(24)
|
(24)
|
(22)
|
(21)
|
(21)
|
(22)
|
(21)
|
(23)
|
(22)
|
|
| Net Income (Common) |
(4)
N/A
|
(5)
-33%
|
(7)
-22%
|
(8)
-24%
|
(12)
-44%
|
(19)
-58%
|
(18)
+5%
|
(16)
+8%
|
(13)
+20%
|
(7)
+48%
|
(7)
-5%
|
(8)
-7%
|
(7)
+6%
|
(7)
+4%
|
(7)
-3%
|
(10)
-38%
|
(11)
-17%
|
(12)
-7%
|
(13)
-3%
|
(17)
-32%
|
(19)
-15%
|
(24)
-25%
|
(27)
-16%
|
(25)
+10%
|
(26)
-4%
|
(25)
+2%
|
(24)
+4%
|
(24)
+0%
|
(22)
+8%
|
(21)
+7%
|
(21)
-3%
|
(22)
-4%
|
(21)
+3%
|
(23)
-8%
|
(22)
+5%
|
|
| EPS (Diluted) |
-316.48
N/A
|
-422.23
-33%
|
-515.55
-22%
|
-641.52
-24%
|
-922.23
-44%
|
-1 398.8
-52%
|
-1 331.59
+5%
|
-1 528.03
-15%
|
-930.81
+39%
|
-399.17
+57%
|
-347.16
+13%
|
-423.65
-22%
|
-342.35
+19%
|
-280.88
+18%
|
-171.38
+39%
|
-263.95
-54%
|
-69.25
+74%
|
-49.79
+28%
|
-47.66
+4%
|
-66.65
-40%
|
-59.5
+11%
|
-74.09
-25%
|
-85.65
-16%
|
-76.89
+10%
|
-80.18
-4%
|
-78.34
+2%
|
-74.92
+4%
|
-68.29
+9%
|
-48.19
+29%
|
-44.87
+7%
|
-46.27
-3%
|
-44.92
+3%
|
-36.69
+18%
|
-39.67
-8%
|
-38.14
+4%
|
|